Beyond Borders: Why Mexico is the New Frontier for Clinical Trials

Beyond Borders: LATAM Clinical Intelligence Webinar Series - Mexican Edition
Topic: Why Mexico is the New Frontier for Clinical Trials

Mexico is rapidly becoming one of the most strategic global hubs for clinical research — and this session explains why.

In this edition of Beyond Borders: LATAM Clinical Intelligence, Farmacon Global brings together leading experts in regulatory law, clinical operations, and ethics committee processes to break down Mexico’s fast-evolving regulatory landscape and what it means for Phase 1–4 clinical trials.

Over the past 18 months, Mexico has undergone major modernization across COFEPRIS, ethics committees, and digital health infrastructure, opening new pathways for biotechs to accelerate approvals, reduce costs, and access diverse treatment-naïve populations.

In this 20-minute executive briefing, you’ll learn:
How COFEPRIS reforms are streamlining protocol approvals and import permits
What digitalization and standardized submission pathways mean for sponsors
How ethics committees are adapting to new national requirements
Key data privacy changes impacting multinational trials
Practical strategies for engaging sites, committees, and regulators early
Why Mexico is now competing — not catching up — in global clinical development

Featured Experts:
Arturo Rodríguez Jacob, CEO & Founder, Infinite Clinical Research – Mexico’s oldest CRO with 25+ years of operational excellence
Julio Copo, Counsel, Arochi & Lindner – Leading authority in Mexican regulatory and data privacy law
Dr. Jenny Solís, Medical Associate, Farmacon Global – 25+ years managing multinational clinical trials across LATAM

Hosted by Sara Tylosky, CEO, Farmacon Global

If your biotech or pharma program is exploring expansion into Latin America, this webinar provides clear, actionable intelligence to de-risk operations and accelerate timelines.

➡️ Subscribe to get notified about upcoming sessions in the Beyond Borders webinar series (Brazil, Colombia, Argentina, and more).

➡️ Learn more at farmaconglobal.com

This session was sponsored by Arochi & Lindner, one of Mexico’s leading Life Sciences law firms, helping global biotechs navigate compliance, IP protection, and regulatory strategy.